Sleep apnea management

Sleep apnea, particularly obstructive sleep apnea (OSA), is a prevalent but often underdiagnosed disorder characterized by recurrent upper airway obstruction during sleep, leading to fragmented sleep, hypoxemia, and cardiovascular stress. Risk factors include obesity, craniofacial abnormalities, male gender, and advancing age. Untreated OSA contributes to hypertension, arrhythmias, metabolic syndrome, and impaired quality of life. Sleep apnea management has expanded significantly beyond continuous positive airway pressure (CPAP), which remains the gold standard therapy. For patients intolerant of CPAP, alternatives such as mandibular advancement devices, positional therapy, and hypoglossal nerve stimulation are showing promise. Weight reduction strategies, bariatric surgery, and lifestyle interventions are essential components of long-term control. Advances in telemedicine now allow remote CPAP monitoring, improving adherence and outcomes. Pediatric sleep apnea, often caused by adenotonsillar hypertrophy, may require surgical intervention. Increasing research links OSA with systemic inflammation and cognitive decline, broadening awareness of its multisystem impact. Screening tools such as home sleep studies are enhancing accessibility to diagnosis, while personalized treatment strategies are improving patient satisfaction. The modern approach to sleep apnea management integrates medical, behavioral, and technological solutions, aiming not only to relieve nocturnal symptoms but also to reduce long-term cardiovascular and neurocognitive risks.